JCB, Volume 23, Number 4, 2017 Commentary Vol.23 No. 4 (2017) Personalized Medicine Needs Enlightened Regulation To Realize Its Potential Henry I. Miller Precision, or personalized, medicine, reflects that treatments -- especially those using biopharmaceuticals -- are gradually shifting from a relatively imprecise "one size fits all" appro Commentary Vol.23 No. 4 (2017) Can there be value-based medicine without … values? Peter J. Pitts “Value-based” is the new, hot prefix. Value-based medicine, value-based insurance design, value-based contracting. It seems that everyone agrees that everything should be based on “ Commentary Vol.23 No. 4 (2017) Biotechnology Can Address the Mystery and Urgency of Alzheimer’s Disease Mina Marmor Alzheimer’s disease (AD), a scourge that in time could virtually bankrupt healthcare systems worldwide, is one of the most intensively researched areas of medicine. Because of t Article Vol.23 No. 4 (2017) Enzymatic approach for bioremediation of effluent from pulp and paper industry by thermo alkali stable laccase from Bacillus tequilensis SN4 Sonica Sondhi Treatments of industrial effluent/s by enzymes offer significant advantage over the use of microorganisms. However they have not been explored for the bioremediation of effluent from pulp Article Vol.23 No. 4 (2017) Application of transgenic biotechnology based on public participation system in China Mei An In recent years, the application of transgenic biotechnology in China has become more and more extensive, but the matched public participation system construction is not optimistic; d Article Vol.23 No. 4 (2017) Statistical Optimization of the production of protease from Bacillus sp. MSK-01 in submerged fermentation Kulwant Kaur Protease has been in increasing demand in industries due to its hydrolytic nature. In industries, high yield of enzyme is required to meet the industrial need at a relatively cheaper cost Article Vol.23 No. 4 (2017) Research on Safety Hazard Control of Genetically Modified Organisms Based on Compensation Laws Chensong Fei In this paper, we firstly analyzed the categories and characteristics of safety hazards of genetically modified organisms. Then, we summarized and compared the laws on safety hazard comp Article Vol.23 No. 4 (2017) A qualitative study among potential manufacturers on the development of ‘Made in Malaysia’ biological products: Challenges and proposed solutions Yvonne Siew Khoon Khoo Aim: To examine the challenges in development of biological products among Malaysian pharmaceutical manufacturers.Methods: We conducted in-depth interviews (IDIs) with senior manag Article Vol.23 No. 4 (2017) International trade legal issues induced by biotechnology and the countermeasures Haiying Zheng Genetically modified products have gradually entered people’s life because of the rapid development of biotechnology. With the perfection and progress of relevant technologies, gene Article Vol.23 No. 4 (2017) Research on Biotech Venture Capital Project Evaluation Zheng Li Biotechnology has been widely used in medicine, environmental protection and food gene research fields, which is playing an increasingly important role in improving the human survival Article Vol.23 No. 4 (2017) A Study on Medical Biotechnology System from Legal Perspective Yeung Lap Fu With the progress and development of science and technology, medical biotechnology has made great progress, which created an objective market and lucrative returns for the medical and Article Vol.23 No. 4 (2017) Impression Products, Inc. v. Lexmark International, Inc.: Is US Supreme Court's Ruling A Pointer To Indian Patent Law On Parallel Imports? Dinesh Kumar Sharma This article attempts to look at the recent significant 7-1 ruling dated May 30, 2017 handed down by the Supreme Court of the United States in Impression Products, Inc. v. Lexmark Internat
